ARCHIVES

FDA Committee IK IL-2/LAK For Modified Group C

This article is from The Cancer Letter archive.

Vol. 13 No. 18 | May 1, 1987

Download PDF Visit The Full Archive

Related Articles

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983

OMB Ploy Would Delay Funding 1,500 NIH Grants From FY 1985 To 1986; Other Cuts Are Considered

January 18, 1985

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

January 30, 2004

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

CHMP Delivers Positive Opinion For Two-Dose HPV Vaccine

February 28, 2014